Primary tabs
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
|
28 |
29 |
30 |
31 |
1 |
2 |
3 |
|
|
|
|
|
|
|
|
|
4 |
5 |
6 |
7 |
8 |
9 |
10 |
|
|
|
|
|
|
|
|
|
11 |
12 |
13 |
14 |
15 |
16 |
17 |
|
|
|
|
|
|
|
|
|
18 |
19 |
20 |
21 |
22 |
23 |
24 |
|
|
|
|
|
|
|
|
|
25 |
26 |
27 |
28 |
29 |
30 |
31 |
|
|
|
|
|
|
|
|
NIH Funding Opportunities
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Notice to Withdraw the Centers for Disease Control and Prevention (CDC) as a Participating Organization from PAR-19-334 entitled "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed"
- Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
- Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
- Reminder of application instructions and policies impacting SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance PAR-19-333, PAR-19-334, and PAR-19-335